兴科蓉医药控股有限公司（06833）于2026年3月2日发布截至2026年2月28日的股份变动月报表，披露报告期内公司已发行股份总数及股本结构未发生变化。
公司法定注册股本为10,000,000,000股，面值每股0.0001港元，总额1,000,000港元。截至2月28日，已发行股份数为2,032,890,585股，与上月保持一致。公司无新增发行、购回、注销及库藏股份变动。
关于期权和激励计划，公司于2025年5月26日采纳的购股权计划在本月并无授出、行使或失效，仍可能发行或转让的股份数量为203,289,058股。
公司在公告中声明已遵守香港联交所《上市规则》及相关法律法规。该公告由董事会主席黄祥彬正式签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.